glp-1 drugs contraindications Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness Dr Medica || Clinical MCQ

GLP-1 Receptor Agonists and Glucagon/GIP/GLP-1 Receptor Dual or Triple AgonistsMechanism of Action and Emerging Therapeutic Landscape in #MASLD Bruno Ramos Molinas Post GLP-1 Receptor Agonists and Glucagon/GIP/GLP-1 Receptor Dual or Triple AgonistsMechanism of Action and Emerging Therapeutic Landscape in #MASLD

2018 Jul;14(7):390-403

Ozempic is also approved to reduce the risk of heart attack, stroke, or death in adults with type 2 diabetes mellitus and known heart disease

That creates a dangerous mismatch

Highlights of Prescribing Information: Ozempic (semaglutide) Injection, for subcutaneous use

Molecular mechanisms of GLP-1 agonists for neuroprotection GLP-1 receptors are functionally expressed in insulin-releasing neuroglia form cells in the rat cerebral cortex, and hyperglycemia significantly increases GLP-1 receptor expression